AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder
Similar Posts
Telehealth Ranked Second-Highest Technology for Improving Patient Outcomes, Following EHR
A new survey by healthcare software provider AdvancedMD has found that telehealth is viewed by medical group employees as…
Medigate Launches Partner-Ready Operational Services (PROS)
Healthcare IoT security leader reinforces its industry commitment by creating a standards-driven approach to healthcare security operations maturity…
Vocalis Health’s COVID-19 Screening Tool Successfully Validated in Large Clinical Study
VocalisCheck obtains CE mark (European Union) approval for medical use as a COVID-19 screening tool Vocalis Health, a company…
CardieX launches CONNEQT to compete with consumer tech giants Apple and Fitbit
Australian medtech CardieX has announced the launch of CONNEQT; a new consumer health division to focus on wearables and…